Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Pancreatitis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 8 articles:
HTML format



Single Articles


    December 2025
  1. THIERENS N, Verdonk RC, Lohr JM, van Santvoort HC, et al
    Chronic pancreatitis.
    Lancet. 2025;404:2605-2618.
    PubMed     Abstract available


    April 2025
  2. STOOP TF, Javed AA, Oba A, Koerkamp BG, et al
    Pancreatic cancer.
    Lancet. 2025;405:1182-1202.
    PubMed     Abstract available


    April 2024
  3. MAITRA A, Topol EJ
    Early detection of pancreatic cancer and AI risk partitioning.
    Lancet. 2024;403:1438.
    PubMed    


    January 2024
  4. KAIMAKLIOTIS PI, Kochman ML
    Prophylactic pancreatic stent placement to prevent pancreatitis after ERCP.
    Lancet. 2024 Jan 11:S0140-6736(23)02719-8. doi: 10.1016/S0140-6736(23)02719.
    PubMed    


  5. ELMUNZER BJ, Foster LD, Serrano J, Cote GA, et al
    Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial.
    Lancet. 2024 Jan 11:S0140-6736(23)02356-5. doi: 10.1016/S0140-6736(23)02356.
    PubMed     Abstract available


    December 2023
  6. WANG S, Wang Y, Zhang Z, Lu W, et al
    Acute pancreatitis as a key to diagnosis of hyperhomocysteinemia in a 12-year-old boy caused by CBS gene mutation.
    Lancet. 2023;402:2235-2236.
    PubMed    


    September 2023
  7. BESSELINK MG, Wilmink JW
    Treating metastatic pancreatic ductal adenocarcinoma: NALIRIFOX as new standard?
    Lancet. 2023 Sep 11:S0140-6736(23)01521-0. doi: 10.1016/S0140-6736(23)01521.
    PubMed    


  8. WAINBERG ZA, Melisi D, Macarulla T, Pazo Cid R, et al
    NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
    Lancet. 2023 Sep 11:S0140-6736(23)01366-1. doi: 10.1016/S0140-6736(23)01366.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.